Loading...
ROCO
6539
Market cap79mUSD
Jul 09, Last price  
42.50TWD
1D
3.66%
1Q
-18.27%
Jan 2017
-94.69%
IPO
-93.80%
Name

Dv Biomed Co Ltd

Chart & Performance

D1W1MN
ROCO:6539 chart
P/E
328.44
P/S
3.20
EPS
0.13
Div Yield, %
4.24%
Shrs. gr., 5y
2.80%
Rev. gr., 5y
-15.21%
Revenues
794m
+38.46%
1,930,451,0001,811,757,0001,827,176,0001,866,166,0001,538,352,000573,573,000794,177,000
Net income
8m
-91.31%
166,280,000301,402,000304,575,000281,258,000162,910,00089,078,0007,737,000
CFO
58m
-51.45%
226,691,000463,070,000522,587,000522,581,000332,339,000119,035,00057,786,000
Dividend
Jun 17, 20260.6 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DV Biomed Co., Ltd. is engaged in the creation, production, and international sale of high-quality, medical-grade dermatological products. The company also extends its services to include wellness and weight management programs, and operates as a distributor for professional aesthetic fillers and advanced medical beauty devices. Complementing these offerings, DV Biomed supplies health-focused food items, such as functional light and energy drinks, alongside a range of facial care and broader beauty solutions. The company was established in 2011 and operates from its headquarters in Taipei, Taiwan.
IPO date
Oct 15, 2015
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT